S-Network Medical Breakthroughs Index

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
As of May 02, 2022

Overview

An index of small and mid-cap biotechnology stocks listed on US stock exchanges that have one or more drugs in either Phase II or Phase III US FDA clinical trials.
Asset class
Equity
Category
Thematic
Region
Global
Rebalance frequency
Quarterly

Tickers

Price return
PMBI
Total return
PMBITR
Net total return
PMBINT

Characteristics

Number of constituents
98
Market capitalization
$150.30 Billion
Adjusted market capitalization
$102.40 Million
Dividend yield

Resources

Composition

Top constituents

As of
December 3, 2024
Company Name
Company Name
Weight

10.8%

Company Name
Company Name
Weight

10.8%

Company Name
Company Name
Weight

10.8%

Company Name
Company Name
Weight

10.8%

Company Name
Company Name
Weight

10.8%

Company Name
Company Name
Weight

10.8%

Company Name
Company Name
Weight

10.8%

Company Name
Company Name
Weight

10.8%

Company Name
Company Name
Weight

10.8%

Company Name
Company Name
Weight

10.8%

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Linked products

Product name
ALPS Medical Breakthroughs ETF
Licensee

ALPS Fund Services, Inc. -SN

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Insights

No items found.
Sign up for index updates to stay in the know.
By clicking submit, you’re opting into communications, subject to our Privacy Policy.
By clicking submit, you’re opting into communications, subject to our Privacy Policy.

Interested in market data packages?

Contact our team for more information.
By clicking submit, you’re opting into communications, subject to our Privacy Policy.